|

Consolidation (Carboplatin, Doxorubicin) -Group D1 Clinical Trials

1 actively recruiting trial

Also known as: Group D1 CD

Pipeline

Phase 3: 1

Top Sponsors

  • Shanghai Children's Medical Center1

Indications

  • Hepatoblastoma1
  • Cancer1

Other1 trial

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.